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The Department of Health and Human Services (HHS) and the Centers for Disease Control and 
Prevention (CDC), National Center for Environmental Health/Agency for Toxic Substances and 
Disease Registry (NCEH/ATSDR), Lead Poisoning Prevention Branch (LPPB) convened a 
meeting of the Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP). The 
proceedings were held on March 18-19, 2008 at the CDC Global Communications Center in 
Atlanta, Georgia. 
Dr. George Rhoads, Chair of ACCLPP, called the meeting to order at 9:07 a.m. on March 18, 
2008. He welcomed the attendees to the proceedings and opened the floor for introductions. 
The list of participants is appended to the minutes as Attachment 1. 
Dr. Mary Jean Brown, Designated Federal Official of ACCLPP and Chief of LPPB, announced 
that voting members with a real or perceived conflict of interest related to any item on the March 
18-19, 2008 ACCLPP agenda would be responsible for identifying these issues and recusing 
themselves from voting on these topics or participating in these discussions. 
Dr. Brown covered the following areas in her update. LPPB recently published two papers in 
response to ACCLPP's activities: "Interpreting and Managing Blood Lead Levels <10 IJg/dL in 
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Children" and "Reducing Childhood Exposures to Lead." She pointed out that LPPB would 
provide copies of the published papers to the public upon request. 
Dr. Brown conveyed that ACCLPP's Laboratory Workgroup has been regularly meeting via 
conference call to focus on the reliability and validity of blood lead testing instruments and also 
to determine whether the analytic error should be reduced from 4 to 2 1J9/dL. The workgroup 
will continue to meet by conference call over the next two months to finalize and present its 
recommendations to ACCLPP for review and formal approval. The workgroup's report 
eventually will be submitted to the Centers for Medicare and Medicaid Services (CMS) or the 
Clinical Laboratory Improvement Amendments (CLlA). 
The workgroup has nearly completed its charge of finalizing and presenting recommendations 
to ACCLPP, but Dr. Brown emphasized the need for these activities to continue. She pointed 
out that LPPB has greatly benefited from the workgroup's knowledge and expertise on issues 
related to LeadCare instruments that are CLiA-waived for saliva lead testing and other emerging 
laboratory issues. She hoped the workgroup would not disband after presenting the final 
recommendations to ACCLPP and would continue to provide guidance to CDC on an ad hoc 
basis. 
Dr. Brown reminded the members that at a previous meeting, ACCLPP unanimously approved 
sending a letter to the International Code Council (ICC). ACCLPP's letter recommended the 
inclusion of lead paint hazards in model codes and standards because this approach is 
consistent with the Healthy People 2010 goal of eliminating elevated blood lead levels (EBLLs) 
and would provide an opportunity to prevent lead exposure in U.S. children. 
Dr. Brown made several announcements regarding ACCLPP's letter to ICC. CDC will update its 
web site with information about ICC's deliberations on April 3,2008. The deadline for the public 
to submit comments on ICC's decision-making process is June 9, 2008. ICC advised ACCLPP 
to resend its letter by this deadline because the letter was sent before the public comment 
period of the hearing process was officially opened. ACCLPP's letter to ICC was distributed in 
the meeting packets for the members to review. 
Dr. Brown reported that LPPB conducted its annual two-week program evaluation course with 
the Harvard School of Public Health. The 12 teams that LPPB sponsored included six state and 
local lead programs, four lead programs funded by the U.S. Environmental Protection Agency 
(EPA), and two environmental health programs. The 2007 program evaluation course was 
LPPB's first effort in sponsoring an international activity. Dr. Brown presented a logic model that 
one of the programs completed on a reproductive health program in the post-conflict area of 
Liberia. 
Dr. Brown highlighted LPPB's key program services, epidemiology and surveillance activities. 
LPPB is now convening its quarterly partners' meetings via "e-meetings" and also is distributing 
quarterly newsletters to ensure that partners are kept informed. 
The non-competitive review of LPPB's cooperative agreement is underway. The program 
announcement contains clear language for grantees to demonstrate capacity in screening 85% 
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of their designated high-risk populations by June 30, 2011 . To achieve this goal, grantees must 
meet the following benchmarks by the end of the current grant cycle: 
• 	 obtain a regulatory or legislative mandate to perform inspections and require lead 
hazard reductions in units where children are lead poisoned; 
• 	 use dust wipe samples for clearance testing; and 
• 	 participate in EPA training programs and other activities. 
LPPB's overarching goal in including the new language in the program announcement is to 
institutionalize a lead poisoning and lead poisoning prevention approach across all CDC-funded 
childhood lead poisoning prevention programs (CLPPPs). Grantees that fail to meet these 
benchmarks within a specified period of time will be penalized. 
LPPB posted screening data from state and local programs for calendar year 2006 by state on 
its web site. Screening data by county will be added to the web site in the near future. 
LPPB was unable to continue its efforts with the Lead Program Area Module. The CDC­
designed database management system was unsuccessful despite extensive funding and other 
resources LPPB devoted to the project. However, LPPB recently completed negotiations to 
adopt a database management system developed by the California Department of Public Health 
that will improve data collection and submission between CDC and grantees. LPPB will make 
the system available to state and local CLPPPs after the system is tailored to be more generiC. 
Dr. Brown reported that LPPB's FY'09 appropriations will slightly decrease. LPPB's operating 
budget for FY'08 is $1 million less than FY'06. LPPB's extramural funds to support cooperative 
agreements were reduced as well. 
Dr. Brown provided an update on LPPB's ongoing efforts to transition to healthy housing. LPPB 
has not been given Congressional authorization to spend childhood lead poisoning prevention 
dollars on healthy housing Initiatives. However, LPPB leveraged funds for healthy housing 
activities from the CDC Coordinating Center for Environmental Health and Injury Prevention 
(CCEHIP) and the Office of Healthy Housing Lead Hazard Control at the U.S. Department of 
Housing and Urban Development (HUD). 
LPPB used CCEHIP funds to support a one-year demonstration project for the city of Baltimore 
to make the transition from a CLPPP to a healthy homes program. During the project, Baltimore 
will determine the types of data that home visitors and inspectors should collect. The contract 
will provide the city of Baltimore with resources to gather information about strategies that were 
implemented to make the transition to healthy housing. 
The demonstration project is expected to result in the development of a "cookbook" that could 
be distributed to other lead programs with an interest in making a transition to healthy housing. 
The cookbook will provide guidance on resources, advocates, training requirements and other 
tools that would be necessary. LPPB plans to present a draft outline of the cookbook during the 
Tri-Agency Conference in September 2008. 
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LPPB requested flexibility in the FY'09 President's budget to spend more dollars on healthy 
housing activities and also to support five underlying principles to make a transition to healthy 
housing. First, housing conditions play an important role in the health of the population. 
Second, the connection between housing and health is complex and requires the expertise of 
multiple scientific and technical disciplines to affect change. Third, the elimination of disparities 
in access to healthy, safe and affordable housing is essential to promoting environmental justice 
and building sustainable communities. Fourth, decision-making in the area of healthy housing 
should be guided by the best available science. Fifth, a recognized and committed workforce 
that is armed with a core set of competencies is critical. 
Dr. Brown opened a competition to rename LPPB in support of its transition to healthy housing. 
The new name of "Healthy Housing/Lead Poisoning Prevention Branch" is being considered. 
However, concerns have been raised that the new name may be misinterpreted to mean LPPB 
is focusing on the "prevention" of both healthy housing and lead poisoning. 
In further support of its transition, LPPB is offering cross-training in lead and healthy housing 
concepts. HUD is providing funds to CDC to incorporate a lead training course into the Healthy 
Housing Training Center Network with 16 academic institutions. The training is designed to 
reach sanitarians, community health nurses and other groups that would not otherwise receive 
lead training. Healthy homes concepts also have been included in lead training sponsored by 
the National Center for Healthy Housing (NCHH) Healthy Housing Solutions Program. 
LPPB will collaborate with EPA on a branding concept for healthy housing. In July 2008, LPPB 
will convene a meeting with CDC-funded CLPPPs that have initiated the transition to healthy 
housing as well as four healthy homes programs funded by CDC's Environmental Health 
Services Branch. The meeting will provide a forum for the programs to explore strategies and 
discuss lessons learned in making a successful transition to healthy housing. 
LPPB is making efforts to develop a science base for healthy housing. CDC, EPA, HUD and 
other federal agencies held a meeting in November 2007 to develop a new healthy housing 
surveillance system. The federal partners reviewed existing data systems, developed 
applications of current data collection systems and documented gaps. 
The interagency meeting resulted in the formulation of a number of recommendations. For 
example, linkages should be made between the American Housing Survey and various surveys 
administered by CDC's National Center for Health Statistics. Relationships should be 
established with local fire departments to collect data on smoke alarm distribution programs. 
The interagency meeting also resulted in several key outcomes. A memorandum of 
understanding (MOU) will be developed to facilitate data sharing across federal agencies. 
Healthy housing grantees or cooperative agreement partners will incorporate data collection 
strategies at local and state levels into the process as funding becomes available. Questions 
will be developed to add to existing surveys. 
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CDC and NCHH convened an expert panel in December 2007 to discuss housing interventions 
and supporting evidence. The expert panel was charged with providing guidance in four 
"buckets:" 
• 	 Interventions that currently have sufficient evidence to recommend immediate 
implementation, such as smoke alarms. 
• 	 Promising interventions that need more testing and evaluation in the field prior to 
recommending implementation. 
• 	 Interventions that need more formative research to determine their effectiveness 
and biologic plausibility. 
• 	 Interventions with no demonstrated record of effectiveness. 
To fulfill its charge, the expert panel was divided into five small groups to review the literature in 
five major areas: (1) interior biological agents (toxins) interventions, (2) interior chemical agents 
(toxics) interventions, (3) external exposures, (4) structural deficiencies, and (5) the intersection 
between housing and community. To advance this initiative, CDC, NCHH and the expert panel 
will continue to weigh the evidence for and against the recommended interventions. Moreover, 
a white paper will be developed to highlight linkages between health and housing. 
lPPB plans to present the draft white paper during the Tri-Agency Conference in September 
2008 for review and comment by grassroots organizations and other participants. A panel of 
-30 decision-makers, advocates and political staff also will be convened during the conference 
to discuss the draft white paper with participants. The primary outcome of this effort will be for 
the participants to suggest concrete suggestions that mortgage companies, insurance agencies, 
code enforcement agencies and other sectors can jointly implement to actually apply housing 
interventions to the field. 
lPPB launched a study on chemical and allergen exposures in green-built versus 
conventionally-built properties. lPPB is collaborating with internal partners within CDC and 
external groups to strengthen environmental collection and sample analysis skills. lPPB hopes 
to enroll one elderly green-built property and one elderly conventionally-built low-income 
property in the study. 
Elderly properties were selected in an effort to identify any long-term problems with green 
construction. The study is designed to test for allergens and chemicals; measure temperature 
and humidity; perform a visual inspection of the property, conduct dust sampling for fungi and 
allergens; and detect volatile organic chemicals, aldehydes and pesticides. 
lPPB is conducting the study due to an upcoming natural experiment. The health benefits of 
green properties will be able to be measured as Section 8 multi-family buildings in the United 
States make a transition to green. The study also might provide an opportunity to identify 
specific green factors that actually contribute to health. The study will include a rigorous cost­
benefit analysis. 
Overall, Dr. Brown acknowledged the need to determine the type of surveillance for lead that 
will be necessary when the prevalence of EBlls is <0.5 1J9/dL. Most notably, pediatricians in 
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the United States will be extremely reluctant to routinely screen children at a low prevalence 
rate. 
ACCLPP thanked Dr. Brown for presenting a comprehensive update on LPPB's activities. 
Several members advised LPPB to provide guidance at this time to inform the development of 
both lead and healthy housing indicators for Healthy People 2020. 
Ms. Jane Malone is the ACCLPP liaison to the Alliance for Healthy Homes (AFHH). She 
provided additional details on the ICC process. ICC held hearings in February 2008 to listen to 
proposals that were submitted for the 2008-2009 cycle. Testimony given during the hearings 
specifically addressed two proposals on lead-based paint (LBP) hazards. Both proposals were 
rejected because ICC requested more clarity and specificity on a standard definition of "Iead­
safe work practices" (LSWPs). ICC also acknowledged that the existing code does not clearly 
define "lead-based paint." 
Ms. Malone reported that ICC would hold final action hearings on the 2008-2009 proposals in 
September 2008. She encouraged ACCLPP members and their constituents to contact AFHH 
to assist in advancing this process. She pointed out that the most critical need at this point is for 
code officials, building department representatives and health department personnel throughout 
the country to become involved in this effort and present a unified voice to ICC. 
On the one hand, Dr. Brown pointed out that ACCLPP did not have a quorum to take a formal 
vote on resending the letter to ICC. On the other hand, she noted that ACCLPP unanimously 
agreed to take this action during a previous meeting, but the letter was sent during the wrong 
time frame. Several ACCLPP members were in favor of sending a revised version of the letter 
to ICC or including new attachments with additional information. 
Dr. Brown emphasized that ACCLPP would need to send the same letter to ICC with no 
changes or new attachments. However, she clarified that individual ACCLPP members are free 
to submit public comments to ICC as private citizens. 
None of the voting members who were present objected to Dr. Brown's suggestion for 
ACCLPP to resend the same letter to ICC with no new attachments. 
mi nn m i i ::::: iii::iii 
OVerview of the ......Ippl CLPPP 
Ms. Lori Genous, Director of the Mississippi CLPPP, explained that the mission of the 
Mississippi CLPPP is to provide case management and follow-up to children with EBLLs, offer 
education and outreach, conduct environmental investigations, and offer guidance on lead 
testing to healthcare providers. The CLPPP is housed in the Mississippi State Department of 
Health (MSDH) Division of Genetics. 
Ms. Genous highlighted a number of milestones in the history of the Mississippi CLPPP. Lead 
screening was initiated in the early 1990s as part of the Early Periodic Screening Diagnosis and 
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Treatment (EPSDT) Program. The first environmental lead investigator was hired in 1994 to 
conduct lead assessments. The first biannual meeting with partners and stakeholders was held 
in 1996 to discuss lead and environmental hazards. 
A system was developed in 1997 to maintain blood lead data. A Lead Advisory Committee was 
established and held its first meeting in 1998. The System for Tracking Elevated Lead Levels 
and Remediation (STELLAR) was first utilized as a surveillance system in 2000. A program 
manager was hired and a health educator was contracted in 2002 to oversee program 
operations and data support. 
The Childhood Lead Poisoning Prevention Guidance document was developed in 2003. CDC 
made an initial site visit in 2004 to evaluate program activities, assess data, and provide 
guidance to assist the CLPPP in improving capacity. Data were submitted to CDC for analysis 
for the first time in 2005. 
CDC awarded cooperative agreement funds in 2006 for the elimination of lead poisoning with a 
comprehensive primary and secondary prevention approach. CDC made additional site visits in 
2006 to offer technical assistance and program support. In 2007, a CLPPP case manager was 
hired, the lead poisoning elimination plan was completed, and a case management protocol was 
created. The development of screening and case management plans is underway. 
Ms. Genous explained that federal legislation currently requires lead screening of all children 
enrolled in Medicaid at 12 and 24 months of age or through 72 months if the child has not 
previously been screened as part of the EPSDT Program. A risk assessment questionnaire is 
administered to children beginning at six months of age, but screening can be performed earlier 
if any of the questions are answered "yes." 
Medicaid requirements for children to receive lead screening in Mississippi include a face-to­
face interview with the head of household, a birth certificate, the parent's proof of birth in the 
United States, verification of income and proof of insurance. For all eligible children, the 
Medicaid specialist will ask the family to select a provider who can perform the following 
services: a comprehensive health and developmental history, phYSical examination, appropriate 
immunizations, BLLs and other laboratory tests, adolescent counseling, health education and 
other anticipatory guidance, and vision and hearing tests. 
Ms. Genous reviewed the CLPPP's data collection process. The CLPPP receives blood lead 
test results from both the MSDH and private laboratories. Of 12 laboratories that report blood 
lead test results, eight submit data to the CLPPP electronically. The CLPPP also receives data 
from -26 private medical clinics that report results monthly from tests analyzed by a handheld 
blood lead testing device. 
Blood lead testing is not universal in Mississippi and the data only represent children in the state 
who are enrolled in Medicaid. The CLPPP uses STELLAR to maintain data and plan program 
activities. STELLAR data showed that 17% of children <72 months of age received a blood 
lead test in Mississippi in 2006. Of 40,794 children tested in 2006, 357 had BLLs ~1 0 1J9/dL. Of 
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357 children with EBlls, 249 had Blls 10-14 jJg/dl and 108 had Blls ~15 jJg/dL. Medicaid 
data in 2006 showed that 198,032 Medicaid-eligible children were ~72 months of age 
Ms. Genous summarized the ClPPP's case management and environmental assessment 
protocols. Mississippi initiates case management when a child has a confirmed venous Bll 
~10 jJg/dL. The laboratory notifies the ClPPP about blood lead test results. The ClPPP 
program manager contacts the child's medical provider to give guidance on retesting and 
informing the family of the blood lead test results. The ClPPP program manager also contacts 
the case manager to initiate case management services. In addition to the case manager, the 
case management team also includes an environmental inspector, medical provider, parent and 
nutritionist if needed. 
The ClPPP implements recommendations from CDC's publication on Managing Elevated Blood 
Lead Levels Among Young Children. Case managers follow CDC's guidance to provide the 
following services. Parents and other members of the public are counseled about lead 
poisoning and prevention. Case managers serve as a liaison between environmental assessors 
and primary healthcare providers to coordinate and implement services. 
Assistance is given to assure the care of the child from initial case identification to final 
resolution. Collaborations are established with housing and environmental agencies to address 
lead prevention and elimination issues. Services are evaluated, advocacy is provided, and 
efforts are made to ensure individual assessment and diagnosis. 
The ClPPP performed environmental assessments only for children with venous Blls ~30 
jJg/dl, and as a result, only 10 were done in 1994. Environmental assessments were performed 
on children with venous Blls ~25 jJg/dl beginning in September 1994; those with venous Blls 
~20 jJg/dl beginning in February 1997; and those with venous Blls 15-19 jJg/dl beginning in 
June 2000. In 2005, the ClPPP's environmentalist initiated telephone counseling to families of 
children with a single venous Bll of 10-14 or 15-19 jJg/dL. In 2007, the ClPPP's case 
manager began providing counseling to families of children with EBlls. 
The ClPPP now performs environmental assessments for children with venous Blls >20 jJg/dl 
or persistent Blls 15-19 jJg/dL. The assessments are conducted where the child spends at 
least six hours per week and include x-ray fluorescence readings as well as soil, dust wipe and 
water samples. Environmental assessments of children with Blls ~20 jJg/dl increased from 65 
children in 1995 to 113 children in 1998. 
The number of dwellings where environmental assessments were conducted decreased from 
116 in 2003 to 65 in 2007. The ClPPP defines "dwelling" as privately owned homes, Head 
Start centers, schools and daycare centers. A school bus and playgrounds at several public 
parks were also included as dwellings in the 2007 environmental assessments. The entire state 
of Mississippi has only one environmental assessor at this time. 
Ms. Genous noted that in >90% of the assessments, hazardous amounts of lead-contaminated 
dust were found in the environment of children with EBlls. Plastic mini-blinds or hazardous 
levels of lead in paint were found in the environment of >50% of children with EBlls. 
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Ms. Elizabeth Foster is a Health Educator in the Mississippi CLPPP. She described the 
CLPPP's outreach and educational activities. The CLPPP will take a number of actions to reach 
specific grant objectives by June 30, 2008. An educational seminar or conference will be 
cosponsored. New partners will be identified and existing collaborators will be enhanced to 
meet the goals of the CLPPP and its partners. Information on at-risk children will be linked with 
asthma programs, Medicaid, the Women, Infant and Children's Program, and other data 
sources. 
The CLPPP has made several accomplishments to date. The Mississippi Children's Justice 
Center is a CLPPP sub-grantee and will disseminate a wealth of information to pediatricians, 
including a risk assessment questionnaire for parents, articles on lead, CDC guidelines for lead 
poisoning, contact information of referral services for parents, and stories for children. The 
CLPPP and Jackson State University are collaborating on the "Hurricane Katrina Partnership" to 
provide faith-based organizations (FBOs) in the Gulf Coast with information on the health effects 
of lead. 
The CLPPP is participating in the "Jackson Roadmap to Health Equity Project" to provide 
communities with information on environmental toxins in neighborhoods and homes. The 
CLPPP developed a statewide fact sheet on lead that is translated and published in a Spanish 
newsletter. The CLPPP partners with the "Communities in School Partnership" initiative to 
provide education on lead to students, teachers and parents. The CLPPP has given continuing 
education units on childhood lead poisoning and lead prevention to 225 childcare employees. 
Ms. Foster highlighted key activities the CLPPP conducts in collaboration with its federal and 
state partners, including Medicaid, the Department of Environmental Quality, HUD and the 
Mississippi State University Extension Service: 
• 	 Provide lead poisoning prevention education and outreach on the hazards of 
LBP. 
• 	 Share data with Medicaid through a formal MOU. 
• 	 Maintain up-to-date lists of certified risk assessors and inspectors in the state of 
Mississippi. 
• 	 Inform the community as well as building and paint contractors about LBP 
hazards and regulations. 
• 	 Monitor housing programs and federal funding related to LBP. 
• 	 Submit quarterly reports to HUD with addresses in the state of Mississippi where 
LBP hazards have been found. 
Educate unlicensed in-home child care providers on childhood lead poisoning. 
• 	 Disseminate lead education materials. 
• 	 Convene video interactive conferences to provide LSWP training to contractors 
and rental property owners throughout the state. 
Of Mississippi's 82 counties, 16 are considered to be high-risk based on a combination of the 
following factors: the proportion of pre-1950 housing units, the proportion of children in poverty, 
the number of children <6 years of age, the lead screening rate, the number of confirmed cases 
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with EBlls ~10 ~g/dl, and the number of addresses where multiple children have had 
confirmed EBlls within the past five years. The 16 high-risk counties accounted for -68% of 
the cases in Mississippi in 2006. 
Ms. Foster was pleased to report that the ClPPP's sub-grantees have conducted outstanding 
educational and outreach activities in the 16 high-risk counties. These initiatives have included 
educational booths at annual state training meetings; completion of the "Is Your Child At Risk?" 
survey; workshops to the Parent-Teacher Association, expectant mothers and childcare 
providers; community health fairs; lead poisoning sessions and an essay and poster contest for 
school children; door-to-door lead poisoning awareness and education; and outdoor festivals for 
families. 
From July 2007 to February 2008, the ClPPP sponsored 22 health fairs and disseminated 
1,635 brochures to 622 participants during these events. The ClPPP also made 18 
presentations at conferences and disseminated 2,768 brochures to 786 participants. During 69 
events, the ClPPP educated 3,540 adults, children and staff from February 2007 to February 
2008. 
Ms. Foster reviewed the ClPPP's major successes to date. The lead elimination plan was 
completed, approved and disseminated. The ClPPP case management protocol was 
implemented. A "Myths Versus Facts" document was developed. The reportable disease and 
conditions list was amended to require reporting of all Blls to the ClPPP. Over 28,000 
childhood lead poisoning prevention materials were distributed. However, the ClPPP 
recognizes the need to address its two key challenges of receiving sub-optimal data and 
obtaining Medicaid reimbursement for case management and environmental assessments. 
Ms. Foster concluded that the ClPPP will participate in a number of conferences and 
workshops throughout 2008. These events will focus on case management and screening 
plans, lead poisoning and asthma, and lSWPs. In the future, the ClPPP will implement more 
housing-based strategies and enhance partnerships to develop investigation and enforcement 
policies. The ClPPP's future activities also include tracking environmental histories on housing; 
continuing to provide training to housing personnel; collaborating with sub-grantees to assist 
with housing-based prevention; and utilizing geographic information system mapping. 
UpdIde on LPN'. Falth-llaeedlCommunlty 0raanJ_tIon Initiative (F8COI) 
Ms. Rose Pue is a Public Health Advisor in lPPB. She explained that Presidential Executive 
Order 13199 was mandated in January 2001 and charged CDC with strengthening and 
expanding the role of FBOs and community-based organizations in addressing the nation's 
social problems. The overarching goal of this effort is to empower America's grassroots 
organizations and increase the confluence between health and faith. 
The FBCOI is important to childhood lead poisoning prevention due to its capacity to engage 
partners in the science and practice of interventions and facilitate collaborations among places 
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of worship, communities and the public health system. The Pew Forum on Religion and Public 
Life recently administered a survey that showed 189 million of 225 million adults in the United 
States reported a religious affiliation. LPPB plans to incorporate the survey findings into the 
FBCOI to determine the number of children <6 years of age in this target population who reside 
in high-risk areas with lead hazards. LPPB also will include the survey data in a comprehensive 
strategy to eliminate childhood lead poisoning by 2010. 
Ms. Pue announced that LPPB is partnering with the Mississippi CLPPP to advance the FBCOI 
and other EJ initiatives. Most notably, technical assistance and resources will be provided to 
religious and grassroots organizations to involve local community residents in lead poisoning 
prevention efforts. Ongoing activities with a demonstrated track record of success will be 
identified. 
Collaborations will be established to conduct proposed initiatives. Contributions will be made to 
evidence-based health outcome information. Appropriate methods will be identified to evaluate 
the effectiveness of the FBCOI in childhood lead poisoning in Mississippi and other areas of the 
country. However, LPPB will not institutionalize the FBCOI until the evaluation is complete. 
Ms. Pue concluded that LPPB addressed concerns related to the separation of church and state 
by designing the FBCOI with three key components. Government actions will have a secular 
purpose. FBCOI activities will not inhibit or advance any religion. The church and state will 
remain separate in all aspects of FBCOL 
Ms. LaToria Whitehead, of LPPB, provided additional details on LPPB's pilot of the FBCOI in 
Mississippi. The environment encompasses all places where persons live, work, play, worship 
and attend school. Strong linkages have been documented among social inequality, public 
health and the environment. Environmental justice (EJ) offers strategies to consider vulnerable 
populations, social injustices and health by seeking justice in situations of injustice. 
EPA defines "EJ" as the fair treatment of all persons in environmental equity by enforcing laws, 
regulations and policies regardless of race, ethnicity or socioeconomic status. EJ is a human 
right rather than an earned right. Presidential Executive Order 12898 also defined "EJ" as 
federal actions that should be taken to address EJ in minority and low-income populations. As a 
result, all federal agencies are charged with integrating EJ into environmental health. 
Minority and low-income populations are more prevalent in childhood lead poisoning than in any 
other public health sector due to the political and economic disenfranchisement of these groups. 
Compared to other groups, minority and low-income populations have more poverty, a stronger 
focus on race and socioeconomic factors, and a disproportionate disparity in health. 
In 1988, the Mississippi Delta Development Commission issued two reports to highlight poor 
housing, economics, education and health dispariUes throughout the state. This initiative 
resulted in the development of an EJ plan to address the needs of underserved populations in 
Mississippi. In an effort to address these gaps in Mississippi, LPPB is including EJ into a 
comprehensive strategy to eliminate childhood lead poisoning by 2010 and is also piloting the 
FBCOI in the state. 
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Ms. Whitehead highlighted key outcomes of the FBCOI pilot in Mississippi. A sub-grantee of the 
Mississippi CLPPP will take policy and legislative actions to ensure housing remediation in the 
state. A health impact assessment will be conducted in two neighborhoods in Jackson, 
Mississippi. An EPA grant, survey data, information from community histories, and results of 
the health impact assessment will be used to emphasize the critical need for remediation of 
housing and changes in other policies to policymakers in Mississippi. 
The FBCOI pilot in Mississippi will be designed to incorporate action, empowerment, capacity 
and a community voice. LPPB will use a number of factors to measure the success of the pilot: 
changes in existing policies, organization of a community-driven process, advocacy to 
policymakers, establishment of a strong infrastructure, and an increase in knowledgeable and 
empowered communities. 
ACCLPP applauded the Mississippi CLPPP on making tremendous accomplishments in a short 
period of time, particularly the submission of quarterly reports to HUD on addresses where LBP 
hazards were found. However, several members were concerned about the ability of only one 
environmental assessor to serve the entire state of Mississippi and the absence of laws to 
enforce actions in housing with poor environmental assessment results. 
Dr. Chinaro Kennedy is the Team Leader of LPPB's Epidemiology and Surveillance Section. 
She described a study that LPPB is conducting with support by HUD to determine the 
effectiveness of primary prevention using state lead risk reduction laws. LPPB acknowledged 
the paucity of data that has been produced to date to examine the effectiveness of state-specific 
lead risk reduction laws in preventing or reducing lead poisoning among children living in high­
risk areas. 
The goal and objectives of the study are to determine whether laws aimed at eliminating 
exposure to LBP hazards resulted in a decline in the number of children who were lead 
poisoned. Conclusions also will be reached on whether states with specific LBP hazard risk 
reduction laws made a significant impact on the prevalence of childhood lead poisoning in high­
risk areas or if those states had a lower incidence of childhood lead poisoning compared to 
states without specific laws. 
Dr. Kennedy reviewed the background and rationale of the study. Lead poisoning continues to 
be an issue in many communities despite the success of preventing lead poisoning in the United 
States through the elimination of lead in paint and fuel. These communities are typically low­
income and dominated by homes built before the elimination of lead in paint products. CDC 
funds 22 state health departments that have implemented specific laws to reduce or eliminate 
childhood lead poisoning. To date, only one study has examined the effectiveness of a state­
specific LBP hazard reduction law in preventing or reducing childhood lead poisoning . 
._--_._---_._-- ------.-------.-.-.--- .. '-'.'-.-.- ....-.- . -.----.... -.-. -_.._-_._-----_.._---------------_._----_. 
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Dr. Kennedy summarized the design, methodology and variables of the study. LPPB will 
conduct a natural quasi-experiment to examine the effectiveness of lead risk reduction laws in 
Massachusetts and Maryland. Both of the intervention states have specific laws that are aimed 
at preventing or decreasing lead poisoning among children living in pre-1978 rental housing. 
Massachusetts has enacted the strictest lead-safe laws in the country, while Maryland has 
passed moderate lead-safe laws. 
Mississippi will serve as the control in the study because the state has not enacted a law 
requiring lead hazard abatement, even for housing where lead-poisoned children have been 
identified. Moreover, the lead poisoning rate in Mississippi is comparable to Massachusetts and 
Maryland. 
The study population will be limited to children <6 years of age with a valid blood lead test. The 
dependent variable will be BLLs ~10 IJg/dL and the independent variable will be LBP hazard 
reduction laws. Covariates will include the child's age, gender, address, insurance type and 
blood lead sample type; income and educational level of the care giver; the year the residence 
was built; case management and environmental assessment histories; and repairs the landlord 
or homeowner made based on a citation. The analysis plan will include both univariate and 
multivariate analyses to calculate means, proportions and frequencies; describe demographic, 
clinical, litigation and environmental data; and assess variances and covariances. 
LPPB developed three key research questions and formulated a number of hypotheses to guide 
the study. First, are state-specific lead risk reduction laws effective in preventing or reducing 
childhood lead poisoning? LPPB's hypothesis is that states with specific laws to reduce lead 
risk in rental properties would have fewer new childhood lead poisoning cases over time 
compared to states without specific lead risk reduction laws. Moreover, the prevalence of lead 
poisoning would be lower in states with specific lead risk reduction laws compared to those 
without lead risk reduction laws, but with comparable housing. Units that are in compliance with 
state-specific requirements would be less likely to have successive children with EBLLs. 
Second, will standardized rates of decline in EBLLs be greater in the intervention states 
compared to the general United States? LPPB's hypothesis is that over a ten-year period, 
standardized rates of decline in EBLLs would be greater in the intervention states compared to 
the general U.S. population. 
Third, do standardized rates of decline in EBLLs differ by counties within the intervention and 
control states? LPPB's hypothesis is that rates of decline in EBLLs would most likely differ by 
county within the intervention and control states. 
Dr. Kennedy highlighted the strengths and limitations of the study. On the one hand, the natural 
experimental design of the study will provide a unique opportunity to examine clinical and 
programmatic ot laws aimed at exposure to an environmental toxin that 
results in adverse health outcomes among vulnerable populations. The study also will 
contribute to the existing body of literature on the reduction of exposure to lead and the 
subsequent development of childhood lead poisoning in the United States. 
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On the other hand, the study will be challenged in identifying actual "treatment" effects due to 
the non-random distribution of both measured and unmeasured factors. Other unmeasured 
covariates might mask or exaggerate the effect between state-specific lead risk reduction laws 
and childhood lead poisoning. The distribution of these risk factors is likely to be unequal 
without randomization. LPPB will make every effort to collect solid data and clearly distinguish 
between the enforcement of laws at state and local levels. 
Several ACCLPP members made suggestions for LPPB to consider in refining the study design 
and methodology. 
• 	 LPPB should include another research question in the study to determine 
whether state-specific lead risk reduction laws or specific activities by state lead 
programs had the most significant impact in preventing or reducing childhood 
lead poisoning. 
• 	 LPPB should design the study to identify tools, personnel and other resources 
that are available to enforce state-specific lead reduction laws. 
• 	 LPPB should use the study to identify actions that are taken when groups or 
individuals do not comply with state-specific lead reduction laws. 
• 	 LPPB should design the study to determine the length of time required to bring 
groups or individuals in compliance with state-specific lead reduction laws and 
identify specific barriers to adherence. 
• 	 LPPB should make every effort to ensure the validity of blood lead tests of the 
study population because the results will vary due to different infrastructures of 
the intervention and control states. 
Updet8 by the Lead and ........ncy Workgroup CLPWG) 

Dr. Jessica Leighton, an ACCLPP member and chair of LPWG, provided a status report on 
LPWG's activities following the September 2007 meeting. She noted that the draft Guidelines 
for the Identification and Management of Pregnant Women with Elevated Lead Levels were 
distributed to ACCLPP for review, discussion and input. 
LPWG made the following revisions to the chapters of the lead and pregnancy report after the 
September 2007 ACCLPP meeting: 
• Chapter 1: Introduction 
• Chapter 2: Adverse health effects of exposure to lead 
• Chapter 3: Biokinetics and biomarkers of lead in pregnancy and lactation 
Chapter 4: Sources and pathways of lead exposure in pregnant women 
• Chapter 5: Blood lead screening and follow-up testing in pregnancy and infancy 
• Chapter 6: Environmental and medical management 
• Chapter 7: Nutritional support 
• Chapter 8: Indications, contraindications and adverse effects of chelation in the 
pregnant woman, fetus and newborn infant 
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• Chapter 9: Breastfeeding 
• Chapter 10: Research, policy and health education needs 
• Chapter 11: Resources and referral information 
Dr. Leighton highlighted key points and recommendations in the lead and pregnancy report. 
The following points are emphasized in Chapter 1: "Introduction." Lead exposure remains a 
public health problem for women of childbearing age, the developing fetus and nursing infant. 
little emphasis has been placed on developing guidelines for prenatal and public healthcare 
providers on the identification, treatment and follow-up of pregnant and lactating women with 
lead exposure. Identifying pregnant women with BLLs .::5 1J9/dL and ensuring a lead-safe 
environment for newborns will prevent adverse health outcomes in these children. 
The following points are emphasized in Chapter 2: "Adverse health effects of exposure to lead." 
Recent evidence suggests that chronic low-level lead exposure has adverse health effects in 
both adults and children. No threshold level for these effects has been identified. Lead is a 
potent reproductive toxicant, but relatively little is known about the biological mechanisms of 
effect. Lead may adversely impact sexual maturation in the developing female and may reduce 
fertility, but evidence is limited. 
Lead exposure has been associated with an increased risk of gestational hypertension. 
However, the magnitude of the effect, the exposure level at which risk begins to increase, and 
the greatest association between risk and acute or cumulative exposure remain uncertain. 
Some evidence supports an association between moderate levels of maternal lead exposure 
and spontaneous abortion. Research has suggested that maternal lead exposure may increase 
the risk of pre-term delivery, but these studies are inconsistent. 
Data are inadequate to establish the presence or absence of an association between maternal 
lead exposure and major congenital anomalies in the fetus. Recent epidemiologic cohort 
studies suggest that even with maternal BLLs <10 IJg/dL, prenatal exposure to lead is inversely 
related to fetal growth and neurobehavioral development independent of effects of postnatal 
exposure. Exact mechanisms remain uncertain. 
The following points are emphasized in Chapter 3: "Biokinetics and biomarkers of lead in 
pregnancy and lactation." No accurate measure of total body lead has been established to 
date. Biomarkers are used to estimate lead body burden and assess lead dose to the fetus 
during pregnancy and to the infant during lactation. BLLs are the most well validated and widely 
available measure of lead exposure. However, a single blood lead measure at a given point in 
time will not provide an accurate indication of cumulative exposure or risk to the fetus or infant. 
Repeat testing might be necessary. 
Bone is a potential source of endogenous lead exposure. Recent studies demonstrate that 
some maternal bone lead are during pregnancy and lactation. However, bone 
lead measurement is a research tool that is not available for routine clinical application at this 
time. Lead readily crosses the placenta by passive diffusion and has been measured in the 
fetal brain as early as the end of the first trimester. As a result, primary prevention of exposure 
is particularly important to reduce risk. Given the difficulty of accurately and precisely 
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measuring trace amounts of lead in human breast milk, routine measurement of breast milk lead 
is not warranted in clinical practice. 
The following recommendations are highlighted to prevent or reduce lead exposure in pregnant 
women in Chapter 4: "Sources and pathways of lead exposure in pregnant women." Clay, soil, 
pottery, paint chips and other non-food items should never be eaten. Jobs or hobbies that might 
involve contact with lead should be avoided, such as construction work, home renovation or 
repair, furniture refinishing, and work involving firearms, arts and crafts, ceramics, stained glass, 
metals or color pigments. 
Imported clay pots and dishes should not be used to cook, serve or store food. Chipped or 
cracked pottery should not be used. Repair work and remodeling on homes built before 1978 
should be avoided. Health remedies and kohl, kajal, surma or other eye cosmetics from other 
countries should be avoided. Caution should be taken when consuming candies, spices and 
snack foods made in other countries. A balanced diet should be eaten with an adequate intake 
of iron and calcium. 
The following recommendations are highlighted for blood lead screening in Chapter 5: "Blood 
lead screening and follow-up testing in pregnancy and infancy." Routine blood lead testing of 
pregnant women is recommended in clinical settings that serve populations at high-risk for lead 
exposure. State or local public health departments should identify high-risk populations of 
pregnant women to guide clinicians in determining the need for blood lead testing. Universal 
blood lead testing of all pregnant women in the United States is not recommended. 
In clinical settings where routine blood lead testing of pregnant women is not indicated, 
healthcare providers should evaluate community-appropriate risk factors for exposure as part of 
a comprehensive occupational, environmental and lifestyle health risk assessment. Blood lead 
testing should be performed if a specific risk factor is identified. 
When indicated, blood lead testing should take place at the earliest contact with the pregnant 
patient and also should be performed using venous blood lead tests. Follow-up blood lead 
testing is indicated for pregnant women with Blls ~5 IJg/dl and their infants. Pregnant women 
with confirmed Blls ~45 1J9/dl should be considered as "high-risk" and managed in 
consultation with experts in lead poisoning and high-risk pregnancies. 
Tables 5-1 through 5-4 contain guidance in the following areas for clinicians and public health 
providers: (1) recommended actions by Bll in pregnancy; (2) the frequency of maternal blood 
lead follow-up testing during pregnancy; (3) follow-up of initial blood lead testing of the neonate 
<1 month of age; and (4) a schedule for subsequent follow-up blood lead testing in infants <6 
months of age. 
The following recommendations are highlighted for avoidance of lead exposure in Chapter 6: 
"Environmental and medical management." Point sources of exposure should be identified and 
eliminated or controlled. Occupational exposures and contact with potential take-home 
exposures to lead should be minimized. Recreational activities that might involve lead exposure 
should be avoided. 
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If renovation, remodeling or repairs are undertaken in homes built before 1978, potential 
exposure to lead paint and dust should be avoided by adhering to EPA's lSWPs, including 
isolation from the work area. Products that might contain lead should be avoided, including 
ceramics, herbal medicines, cosmetics, foods, spices, candies and other culturally-specific 
products produced outside of the United States. Drinking of lead-contaminated tap water 
should be avoided by using bottled or filtered water or flushing the tap. Pica behavior is 
common among women identified with high Blls in pregnancy and should be assessed and 
discouraged. 
The following medical management recommendations are highlighted in Chapter 6. For women 
with prenatal Blls ~15 IJg/dl, management should include an environmental risk assessment 
by corresponding local or state health departments with subsequent source reduction and case 
management activities. Pregnant women with confirmed Blls ~45 IJg/dl should be considered 
as "high-risk" and managed in consultation with experts in lead poisoning and high-risk 
pregnancies. Pregnant women with confirmed Blls <45 1J9/dl should be retested according to 
the schedules in Chapter 5 and Chapter 9 if breastfeeding. 
Chapter 7 is a new chapter on "nutritional support" and is currently being developed. 
The following recommendations are highlighted for chelation therapy in Chapter 8: "Indications, 
contraindications and adverse effects of chelation in the pregnant woman, fetus and newborn 
infant." Chelation treatment should be considered for pregnant women with Blls >45 1J9/dl 
and if organogenesis is complete (i.e., after the first trimester). The decision to chelate should 
be performed in consultation with experts in lead poisoning and high-risk pregnancies. 
Pregnant women with life-threatening lead encephalopathy should be chelated regardless of the 
trimester. Before considering chelation therapy in the pregnant woman or infant, Blls should 
be repeated and confirmed using an additional venous blood lead sample collected within 24 
hours. Chelation treatment must occur in a lead-free environment. 
Pregnant women with confirmed Blls ~45 1J9/dl should be considered as "high-risk" and 
managed in consultation with experts in lead poisoning and high-risk pregnancies. Infants 0-6 
months of age with confirmed Blls ~45 1J9/dl should be considered as candidates for chelation 
in consultation with a pediatric expert in lead chelation therapy. Insufficient data exist regarding 
the advisability of chelation for pregnant women with Blls <45 1J9/dL. 
The following recommendations are highlighted for breastfeeding in Chapter 9. The purpose of 
these recommendations is to protect the nursing infant from exposure to unacceptable amounts 
of lead from breast milk. Therefore, the emphasis is on the infant's BlL. Care of the mother 
should conform to all current guidelines and be cognizant of recommendations for the 
management of adults. 
If the maternal Bll closest to delivery or the infant venous Bll is ~5 IJg/dl, the infant should be 
monitored according to the schedule in Chapter 5. If Blls ~5 1J9/dl persist in the nursing infant, 
extra attention should be paid to the identification of ongoing sources of lead. The concern 
-_.-._._----_.•.._.. _---_. 
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regarding infant Blls ~5 J,Jg/dl must be balanced against recognized benefits of breastfeeding. 
The decision to discontinue breastfeeding is not desirable at infant Blls <44 J,Jg/dl unless a 
thorough investigation of the child's environment has revealed no quantitatively important 
sources of lead other than the mother's milk. Infant Blls ~45 J,Jg/dl are cause for immediate 
concern. 
lactating women who become pregnant during lactation should be followed in accordance with 
the schedule for pregnancy. Infant formula that requires reconstitution should be prepared with 
bottled or filtered tap water. At a minimum, cold tap water should be used only after the line is 
sufficiently flushed for at least three minutes prior to use. State and local authorities should 
consider recommendations on lead levels in local tap water in regard to the use of such water in 
preparing infant formula. 
Data do not exist to accurately weigh the risks of lead exposure from breast milk against the 
benefits of breastfeeding at maternal Blls 20-40 J,Jg/dl,. At these levels, the woman may 
continue to breastfeed if sequential Blls of the mother and infant are performed to monitor 
trends in Blls. Women with confirmed Blls ~40 J,Jg/dl should not breastfeed. 
Tables 9-1 through 9-4 contain guidance in the following areas: (1) the frequency of maternal 
blood lead follow-up testing during lactation to assess the risk of infant lead exposure from 
maternal breast milk; (2) recommended values estimated for breast milk by age in months; (3) 
the estimated daily intake of lead from breast milk at different maternal blood lead 
concentrations; and (4) estimated infant blood lead concentrations associated with different 
maternal blood lead concentrations. 
The following research needs are highlighted in Chapter 10: 
• 	 Fundamental research needs 
Chelating agents 
long-term prospective studies 
Follow-up studies of pregnancy outcomes and infant development 
Bll prediction 
Therapeutic agents for Blls <45 J,Jg/dl 
Thresholds for adverse affects 
lead absorption 
Synergistic effects from multiple metal exposures 
Gene-environment interactions 
• 	 Intervention studies 

Nutrient supplements 

Nutrient supplementation and biokinetics 

Traditional medicines 

Pica risk 

Behavior modification for pica 
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• 	 Treatment strategies 
Education and developmental support 
Health education 
Cost and benefits of environmental interventions 
• 	 Screening efficacy 
Costs of testing and follow-up care 
Validation of risk assessment questionnaires 
Alternative screening 
Timing of blood lead testing during pregnancy 
Cost and benefits of adolescent screening 
Cost and benefits of multiple metal testing 
Cost and benefits of filter paper testing 
• 

• 	 Policy 
Reimbursement for testing and follow-up 
Regulation of contaminated cultural products, traditional medicines and 
dietary supplements 
Warning labels 
Inter-country reporting 
Control of LBP hazards 
• 	 Health education 
Incorporation of environmental health requirements into the basic health 
practitioner's curriculum 
Resources to assist health practitioners in collecting information on 
sources of lead exposure 
Solid examples of health education materials to collect, validate and 
disseminate 
Dr. Leighton emphasized that LPWG's next steps would be to continue to refine the lead and 
pregnancy document, particularly to develop the new "nutritional support" chapter; extensively 
revise the "research needs· chapter; and ensure consistency of the text across all chapters. 
Dr. Leighton reminded ACCLPP that Dr. Adrienne Ettinger, of the Harvard School of Public 
Health, is an LPWG member and editor of the lead and pregnancy report. She asked ACCLPP 
to submit additional feedback in writing to Dr. Ettinger with the page and line number identified 
for each comment. Drs. Ettinger and Warren Friedman, ACCLPP's ex-officio member for HUD, 
agreed to engage in an offline discussion regarding the language on a "lead-free" versus a 
"lead-safe" environment in Chapter 8. 
Dr. Brown described CDC's next steps in finalizing, publishing and disseminating the lead and 
pregnancy report. After the draft report is finalized by LPWG and formally approved by 
ACCLPP, the document would be submitted to the CDC clearance process and the Office of 
--.----------­
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Management and Budget (OMB) external peer review process. The document would be revised 
based on these two processes, posted on the CDC web site for public comment, and re-revised 
based on the public comment period. The final report would be published in the Morbidity and 
Mortality Weekly Report or as a stand-alone document in a peer-reviewed journal. 
Dr. Brown noted that in addition to drafting the lead and pregnancy report, LPWG is also 
charged with developing a rollout plan to disseminate the document. For example, an executive 
summary of the report or a succinct action guide could be developed and given to state and 
local health departments for further distribution to advocates, elected officials and other 
constituents. 
ACCLPP applauded LPWG on the tremendous progress that was made after the September 
2007 meeting to draft the lead and pregnancy report. ACCLPP particularly acknowledged Dr. 
Ettinger's diligent efforts, commitment and contributions to this initiative. 
Several ACCLPP members made suggestions for LPWG to consider in its ongoing efforts to 
revise the report. 
• 	 Chapter 2: A meta-analysis should be performed to formally review existing 
studies on prenatal blood lead and cognitive effects. An additional table should 
be included to clearly summarize these findings. 
• 	 Chapter 4: A new recommendation should be added for pregnant women to 
avoid exposure when renovating or remodeling older homes. 
• 	 Chapter 4: The EPA Lead and Renovation Rule should be added as a new 
reference. Congress has urged EPA to issue the rule no later than March 31, 
2008. 
• 	 Chapter 4: The recommendation to avoid eye cosmetics should be expanded to 
include other cosmetics. 
• 	 Chapter 4: The recommendation to avoid jobs that may involve contact with lead 
should be revised because some pregnant women would be unable to follow this 
guidance due to economic reasons. 
• 	 Chapter 4: The recommendation to avoid hobbies that may involve contact with 
lead should be revised to clarify "construction work, renovation or repair of 
homes built before 1978." 
• 	 Chapter 5: The reference to "see Table 5-1" should be deleted from the box of 
key recommendations. 
• 	 Chapter 5: New language should be added to clarify that universal blood lead 
screening is not recommended, but universal screening with questions for high­
risk behaviors is recommended. 
• 	 Chapter 5: New language should be added to provide clinicians and public 
health providers with more information on risk factors for high-risk populations, 
such as living near a smelter or having a large proportion of recent immigrants in 
the community. 
• 	 Chapter 5: The language stating that "universal blood lead testing of all pregnant 
women in the United States is not recommended" should be placed as the first 
rather than the third bullet. 
---_._- ---------------------- -_._----­
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• 	 Chapter 5: The recommendation should be changed to evaluate "community­
specific" rather than "community-appropriate" risk factors. 
• 	 Chapter 6: The section on "safe home repair, remodeling and renovation" should 
be revised after EPA releases the Lead and Renovation Rule. 
• 	 Chapter 9: The recommendation should be reviewed to clarify whether the infant 
venous BLL or cord BLL should be monitored. 
• 	 Chapter 9: New language should be added to emphasize that ACCLPP 
expressed special concerns regarding BLLs 5-9 1J9/dL in children <6 months of 
age. 
• 	 Chapter 9: New language should be added to explain that women with EBLLs 
who wish to breastfeed should consider both breastfeeding and supplementing 
with formula to diminish the net intake of lead to the infant. 
• 	 Chapter 10: An analysis should be performed to identify the cost and feasibility 
of filling the research needs. 
• 	 Chapter 10: The research need of "determining the blood lead threshold for 
adverse effects in vulnerable populations" should be deleted because the 
language suggests that a safe level for lead exists. 
• 	 Chapter 10: The entire chapter on research needs should be extensively edited 
because many of the recommendations extend beyond the focus of the 
document on lead and pregnancy. 
• 	 Chapter 10: The chapter should be structured with the same format as the other 
chapters; focus on the same population of pregnant women and young infants; 
and divided into specific sections, such as research needs on screening, the 
relative risk of certain BLLs and treatment. 
• 	 Chapter 10: The policy research needs should be stratified by recommendations 
to federal, state and local agencies due to differences in regulations among state 
and local health departments. 
• 	 Chapter 10: New language should be added to provide guidance on applying the 
policy recommendations in countries other than the United States. 
• 	 Chapter 10: The health education research needs should be expanded to 
highlight additional resources: 
Training, materials and other resources to consumers, medical schools 
and employers. 
Partnerships with professional societies to introduce lead and pregnancy 
and broader environmental health issues to healthcare providers during 
national conferences. 
Continuing medical education (CME) to providers. For example, 
ATSDR's online curriculum offers CME and was recently updated to 
include both childhood and adult lead poisoning. 
Ms. Valarie Johnson is an ACCLPP member. She described advocacy efforts that are being 
undertaken to use developmental delay to provide educational support and other services to 
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children with EBlls. The "Kinship Project: learning and Living With lead" is a collaborative 
effort that is jointly conducted by Urban Parent to Parent and Advocates for Educational Equity 
and Excellence (A4EEE). The Kinship Project is guided by the following educational initiatives: 
• 	 Infants and toddlers enrolled in Part C of IDEA. 
• 	 Preschool to school-aged children who are making a transition from Part C to 
Part B of IDEA. 
• 	 Students in grades K-12 who are enrolled in IDEA Part B. 
• 	 Resources and support provided by the "No Child left Behind" program. 
• 	 Disproportionate factors in urban special education programs. 
• 	 Policy and family educational advocacy efforts. 
Ms. Johnson explained that a strong focus has been placed on childhood lead poisoning 
prevention of children 1-2 years of age due to numerous factors. Normal hand-to-mouth activity 
is most common in this age group. Crawling and other behaviors result in infants and toddlers 
coming into contact with lead dust in the home. The bodies of infants and toddlers absorb more 
lead than older children or adults. The impact of lead is greater because the brain and other 
body organs of infants and toddlers rapidly develop. 
Ms. Johnson emphasized the critical need for parents, advocates, school systems and other 
stakeholders to use developmental delay as a mechanism to access services for children early 
in the process. To support the effort of linking lead poisoning to educational outcomes, she 
asked ACClPP to provide input on two key questions. First, what strategies can be 
implemented to ensure that infants and toddlers with lead poisoning have access to provisions 
under Part C of IDEA? Second, what approaches can be taken to continue the dialogue on the 
educational needs of children who live with lead? 
Ms. Cassandra Archie, of A4EEE, provided additional information on IDEA. The Kinship 
Project was developed due to the importance of accessing and interpreting information to 
effectively use IDEA as a tool to provide services for students with developmental disabilities. 
IDEA is a federal grant program that assists states in operating a comprehensive statewide 
program of early intervention services for infants and toddlers 0-2 years of age and their 
families. 
IDEA was established in 1975 with four components. Part A provides administrative resources 
to states. Part B gives provisions to children in grades K-12. Part C provides services to infants 
and toddlers through two years of age. Part D provides "research-to-practice" funding to Parent 
Information Centers and other initiatives. 
Ms. Archie reviewed a number of key points in IDEA Part C. Congress emphasized an urgent 
and substantial need to enhance the development of infants and toddlers with disabilities, 
minimize their potential for developmental delay, and recognize significant brain development 
that occurs during the first three years of a child's life. The 27th Annual Report of IDEA Part C 
found that -2.2% of children born receive special education services. States are not required to 
report the proportion of infants in this population who receive services due to EBlls. In 2002­
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2003, 66% of infants and toddlers enrolled in IDEA Part C were determined to be eligible for 
Part B services. 
IDEA Part C provides services to infants and toddlers through two years of age who are 
experiencing developmental delay. Federal funds are allocated to all 50 states to implement 
this provision of the law, but states have different criteria and eligibility requirements to 
determine "developmental delay." The law also gives states discretion to focus on infants and 
toddlers who are at risk. However, only eight states use discretionary Part C dollars to provide 
services to at-risk infants and toddlers. 
Ms. Archie reviewed a number of key points in IDEA Part B. This provision of the law provides 
services to children three years of age with developmental delays. Each state that receives Part 
B dollars maintains a 619 coordinator to oversee regulatory requirements of the program and 
coordination of funds. Although the law specifically defines developmental delays for children 3­
9 years of age, states are given discretion to create a subset of this age group. As a result, 
most states limit developmental delays to children 3-5 years of age under IDEA Part B. 
IDEA Part B is structured with 13 federal classifications for students that each state is required 
to report to Congress. lead poisoning is included in the "other health impaired" (OHI) 
classification, but this condition is not officially defined in the law. However, lead poisoning is 
listed as one of the examples in the federal regulations for the OHI classification. 
The OHI classification is defined in federal regulations as having limited strength, vitality or 
alertness, including heightened alertness with respect to the educational environmental, that is 
due to chronic or acute health problems, such as asthma, attention deficit disorder, attention 
deficit hyperactive disorder (ADHD), diabetes, epilepsy, a heart condition, hemophilia, lead 
pOisoning or leukemia. 
The federal regulations further state that these conditions must adversely affect the child's 
educational or functional performance. The largest proportion of children with EBlls most likely 
would fall under the "learning disabled" and "multiple disabilities" classifications of IDEA Part B. 
Because states have discretion in developing and interpreting eligibility criteria for lead 
poisoning and other conditions under Part B, many children with developmental disabilities who 
are eligible for IDEA are not receiving services. 
Ms. Archie urged ACClPP to use its scientific expertise to raise awareness within IDEA about 
the impact of EBlls on learning. She confirmed that advocacy efforts could playa significant 
role in improving IDEA for children because grassroots organizations convinced Congress to 
include autism as an IDEA classification. She announced that the reauthorization of regulations 
under IDEA Part C is underway. The public comment period closed in July 2007, but the 
proposed regulations have not been finalized to date. However, states will no longer be able to 
use IQ discrepancies alone or IQ as a measure for IDEA eligibility beginning in 2010. 
ACClPP thanked Ms. Johnson and Ms. Archie for giving an informative and helpful 
presentation. Dr. Brown noted that time was set aside on the following day for ACClPP to 
discuss potential action items and future activities related to educational intervention strategies. 
- ----_._---------- ------------
ACClPP Meeting Minutes Page 23 March 18-19,2008 
Dr. Friedman announced that 34 C.F.R. 300.7(c)(9)(i) is the Department of Education regulation 
that governs the inclusion of lead poisoning in IDEA Part B. 
Dr. Vivian Cross is the Executive Director of the Foundation for Educational Advancement, Inc. 
of Connecticut (FEACT). She announced that the state of Connecticut extensively discussed 
the classification of OHI due to lead pOisoning for two years. The Parent Handbook for Special 
Education mentioned OHI due to lead poisoning and listed a number of categories, but lead 
poisoning and sickle cell anemia were excluded. However, the entire handbook was later 
revised to explicitly include OHI due to lead poisoning. 
Dr. Cross reiterated Ms. Archie's concern that children with developmental disabilities who are 
eligible for IDEA are not receiving services. She hoped ACClPP would establish a new 
workgroup to address this issue. 
With no further discussion or business brought before ACClPP, Dr. Rhoads recessed the 
meeting at 4:35 p.m. on March 18, 2008. 
Dr. Rhoads reconvened the ACClPP meeting at 9:10 a.m. on March 19, 2008 and yielded the 
floor to the first presenter. 
Ms. Anne Evens is a Ph.D. candidate at the University of Illinois, Chicago School of Public 
Health. She described local research efforts that are underway to match blood lead testing with 
school readiness or performance. 
Study 1 was conducted by the state of North Carolina to determine whether Blls in early 
childhood were related to educational achievement in early elementary school as measured by 
performance on end-of-grade testing. The study was published in August 2007. 
The study design and methodology included educational testing data for fourth grade students 
in four cohorts from 2000-2004. Data were collected from the North Carolina Education 
Research Data Center and linked to blood lead surveillance data for seven counties in North 
Carolina. The data were analyzed using exploratory and multivariate statistical methods. Blls 
were linked to fourth grade reading and math tests. Of 8,600 children in the data set, 55% were 
African American and 49% were white. 
The percentage of children with blood lead results varied from 20%-50% among the seven 
counties. The study was controlled for educational level of the parent, enrollment in a certain 
school system or district, and household income based on participation in a free or reduced 
lunch program. Children who spoke English as a second language were excluded from the 
---------_._-----_._-----­
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study. The major limitation of the study was the exclusion of maternallQ or home environment 
score. 
The results and conclusions of the North Carolina study are summarized as follows. A strong 
association was seen between a Bll of 5 jJg/dl and a decline in reading and math scores. This 
impact was found to be extremely significant in comparison to covariate effects that are typically 
considered to be profoundly influential on educational outcomes. Early childhood lead 
exposures appeared to have a greater impact on performance for the reading rather than the 
math portions of the tests. 
The impact of lead on standardized test results was sufficient to ensure that some children who 
would have otherwise passed the grade were failed. lead was found to impact retention rates. 
Blls and income as measured by participation in a free or reduced lunch program had 
comparable impacts on test scores. North Carolina plans to expand the study to more counties 
and follow children through high school. 
Study 2 is currently being conducted by the city of Chicago with five birth cohorts of children 
born in 1994-1998 and enrolled in Chicago public schools. Administrative data sets were 
matched to birth registry data, blood lead data and school performance data. The number of 
children in the study with both health department and school records totaled 144,080. 
The Chicago study was designed to answer three research questions. Do children with higher 
Blls score significantly lower on standardized tests than those with lower Blls? Do children 
with higher Blls receive special education services at a significantly higher rate than those with 
lower Bll results? What are the increased costs of providing educational services to children 
with lead poisoning? 
Several requirements and guiding principles were identified to inform the study. All children in 
Chicago are considered to be at high risk for lead poisoning. The Chicago Department of Public 
Health (CDPH) requires blood lead testing at school entry; entry into any licensed preschool or 
daycare program; and enrollment in Medicaid at 1 and 2 years of age. CDPH also has 
developed broad guidelines to screen all children six months to six years of age in Chicago. 
Blood lead testing rates in Chicago are 30% for children one year of age and >90% for school­
aged children. 
The study design and methodology included a log of school failure, information on the use of 
special education services, and the Illinois and Iowa Achievement Tests as school performance 
measures. These tests are administered to all children at several grade levels. Multiple 
measures were used to determine exposure to lead, including Blls at two years of age, peak 
Blls, areas under the curve and concurrent Blls. Data were collected from the birth registry 
database to determine specific covariates, such as socioeconomic status of the parent, medical 
information on prenatal care and birth of the child, and maternal and paternal ages and 
education. 
Of -28,000 children in each of the five birth cohorts from 1994-1998, 41% were African 
American, 34% were white, 21% were Hispanic, 89% received either free or reduced lunch, and 
---------
-------_._-----­
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7% had an individualized education plan. In terms of maternal education, 75% of mothers 
completed high school and 20% completed college. Data are still being collected for the 
Chicago study at this time, but preliminary results are expected to be generated by the end of 
2008. 
Study 3 is currently being conducted by the state of Rhode Island as an intervention study to 
examine the relationship between lead poisoning and kindergarten readiness. Administrative 
data sets were matched with blood lead results and reading readiness measured at the 
beginning of kindergarten. In Rhode Island, 90% of children have a blood lead test at school 
entry. 
The study was designed to evaluate whether children with low reading readiness scores and 
EBlls benefited from focused reading skill classes as measured by a follow-up reading 
readiness assessment. This intervention was studied in previous research and was shown to 
be successful. The study population included -4,500 children in three school cohorts from 
2004-2006. Data are still being collected and refined for the Rhode Island study at this time, but 
preliminary results are expected to be generated by the end of 2008. 
Study 4 is currently being conducted by the state of Connecticut to examine the relationship 
between lead poisoning and grade school performance. Blood lead results were collected for 
-25% of children in the study. The Developmental Reading Assessment and the Connecticut 
Mastery Test that is administered to children in grades 3-9 were used to measure school 
performance. 
Ms. Evens highlighted a number of potential policy outcomes from the studies: 
• 	 Increased interest in linking local data with health and school performance data. 
• 	 Increased emphasis on school performance testing and retention in the "No Child 
left Behind" Program, particularly in response to the North Carolina study that 
showed an impact of lead exposure on retention. 
• 	 Increased interest among education advocates. 
• 	 A closer working relationship between health and education departments. 
• 	 Increased attention on school readiness with opportunities to improve health 
outcomes across a number of indicators. 
• 	 Additional research efforts to quantify the cost of lead poisoning to public school 
systems, provide local data, facilitate policy change at the local level, and 
leverage more funding for primary prevention at local and state levels. 
Ms. Evens announced that the study investigators have convened an informal research 
workgroup to make the studies more consistent and robust. She made three requests to 
support this effort. First, CDC should distribute the completed studies to ClPPPs to take action 
on the findings and explore the possibility replicating the studies in the future. Second, 
ACClPP should provide the study investigators with information on additional research efforts 
on lead poisoning and school performance. Third, ACClPP should provide input on whether 
the designs, methodologies and research questions of the studies are appropriate. 
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Dr. Snodgrass advised the study investigators to review the extensive pediatric literature on 
various enrichment programs for cognitive behavioral developmental outcomes and 
improvement in younger children beginning at one year of age. He pointed out that these 
studies demonstrated improvements in cognitive outcomes with enrichment programs and other 
early intervention activities in other settings. 
Dr. Cross dedicated her presentation to innocent children who need crucial early intervention, 
special education or other related services as a result of being victims of, impaired by, or dying 
from lead poisoning. She described completed and ongoing efforts in Connecticut to address 
the intersection between health education and childhood lead poisoning. 
A HELP public service announcement was broadcast in Connecticut. A diverse group of 
legislators, policymakers and community representatives was convened to specifically focus on 
HELP issues. A statewide conference was held with educators representing 26 school districts. 
A survey was administered during the conference and showed that 58% of educators in 
attendance answered "true" or "I don't know" to the question of whether the human body needs 
a small amount of lead for good nutrition. 
A legislative and informational forum was convened with multiple state agencies representing 
the sectors of public health, policy, education and developmental services. This effort was 
undertaken because the Connecticut State Department of Education was excluded as a state 
partner in the Lead Task Report and Recommendations. 
The initial forum resulted in additional regional, state and local forums; the establishment of the 
Connecticut Childhood Lead Poisoning Elimination Task Force; and the development of a plan 
to eliminate childhood lead poisoning in Connecticut by 2010. The overarching objective of the 
Lead Task Force and follow-up forums was to facilitate a collaborative effort rather than a silo 
approach among all health, provider and educational service agencies throughout the state. 
Students, legislators, foundations, health officials and other stakeholders in the state of 
Connecticut participated in a historic lead legislation press conference. The governor officially 
named January 31 as Connecticut's "Health Education Lead POisoning Day." 
A national lead survey was administered to determine the educational implications of childhood 
lead poisoning. Of 111 survey respondents representing 29 states, either 100% or 99% 
identified five key needs to advance HELP activities: 
• 	 Early intervention services for lead-poisoned children. 
• 	 Professional development and training for educators and health professionals. 
• 	 Higher education course requirements for health, education and social service 
providers. 
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• 	 Federal and state guidelines or policies to identify, evaluate and provide services 
to impaired children who qualify for services under IDEA or Section 504 of the 
Rehabilitation Act. 
• 	 Universal lead screening for all children 1-3 years of age in Connecticut. 
Dr. Cross highlighted additional HELP activities that are underway in Connecticut. Universal 
blood lead screening will become effective in Connecticut beginning in January 2009. FEACT 
established a web site at wwwJeactorg and has received 19,085 hits from 21 countries over the 
period of October 2006 to March 9, 2008. To date, nearly 350 educators throughout the state 
have received HELP training and continuing education from nationally renowned experts. 
A survey was administered during the Connecticut Educators Forum in January 2008. Of all 
survey respondents, either 100% or 98% identified four critical needs to advance HELP 
activities: 
• 	 Lead-safe schools, preschools and Head Start facilities. 
• 	 Research to identify the magnitude of childhood lead poisoning in Connecticut. 
• 	 Early intervention services for lead-poisoned children <6 years of age. 
• 	 Guidelines or policies to identify, evaluate and provide services to children who 
qualify for services under IDEA or Section 504 of the Rehabilitation Act. 
Dr. Cross conveyed that the HELP initiative was established with a multifaceted and 
multidisciplinary group of stakeholders to keep children lead-safe and lead-free and also assist 
children who are impaired due to lead poisoning. Photographs of normal brain development 
and the impaired brain of a lead-exposed child are presented during HELP training sessions to 
illustrate the disruption of lead on neural stem and precursor cell growth. 
Efforts are underway in Connecticut to adopt three models of diagnostic assessments and 
interventions to make further progress on HELP activities: (1) a neurodevelopmental 
assessment and intervention model supported by the "All Kinds of Minds" and "Schools Attuned" 
programs; (2) a structural cognitive modifiability model supported by the "Learning Propensity 
Assessment Device" and "Instrumental Enrichment Program;" and (3) a child development 
model supported by the "School Development Program." 
Dr. Cross outlined Connecticut's next steps to advance HELP activities. Additional progress will 
be made on the landmark Duke University study with support from the Connecticut Speaker of 
the House, several state agencies, foundations and communities. More actions will be taken to 
discontinue the current practice of denying crucial services to lead-poisoned children. 
Efforts will be made to increase compliance with IDEA Parts Band C and Section 504 of the 
Rehabilitation Act. A call to action will be launched on behalf of lead-impaired children. A 
request will be made for CDC to convene a workgroup or task Force to address the health 
education needs of children who are impacted or impaired as a result of exposure to lead. 
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Dr. Martha Wood is the Director of SCEL. She explained that SCEL was founded with a 
number of principles, including the Learning Propensity Assessment Device, cognitive 
functioning, structural cognitive modifiability and brain plasticity. These concepts are supported 
by brain research that shows the brain can be retrained for individuals to learn. 
SCEL is guided by an assessment component and the "Instrumental Enrichment" intervention 
that was expanded to include children three years of age through adulthood. The intervention is 
designed with a basic program for young children and a standard program for public schools or 
one-on-one intervention. 
SCEL provides training to teachers in using the Instrumental Enrichment intervention. The 
program requirements include 40 hours of training for each year of the three levels of 
implementation. SCEL acknowledges that if specific cognitive deficiencies in children are 
diagnosed, prerequisites for learning can then be identified. 
ACCLPP applauded the speakers for making comprehensive presentations on ongoing 
research and successful models of educational intervention strategies at state and local levels. 
Dr. Rhoads opened the floor for ACCLPP to discuss, provide input or suggest next steps in 
focusing on the relationship between lead-exposed children and educational interventions. 
• 	 The lead poisoning and school performance studies should be designed to 
collect more data on the actual impact of educational interventions on redressing 
school performance of lead-exposed children. 
• 	 The lead poisoning and school performance studies should be controlled for 
ADHD to determine interactive or primary effects. 
• 	 The Chicago study should be designed to gather data from the legal system and 
link to existing longitudinal cohorts. This approach could be used to collect 
information in a cost-effective manner to determine the long-term consequences 
of adults who were lead poisoned as children. For example, ICF International 
has published papers on the relationship between adult criminal activities and 
early childhood lead exposure. ICF's research questions, approach, design and 
methodology could be adapted to the ongoing lead poisoning and school 
performance studies. 
• 	 Data should be collected in the lead poisoning and school performance studies to 
answer additional research questions: (1) Should interventions be prolonged 
until a child shows developmental delay or should the risk factor of lead exposure 
make the child presumptively eligible for developmental delay? (2) Is a regular or 
specialized form of enrichment required for the lead-exposed brain that learns 
differently? (3) What is the best age group to target educational interventions to 
young children and receive the most significant impact? 
• 	 ACCLPP should formulate recommendations that are specifically targeted to 
CDC's public health mission. For example, ACCLPP could provide guidance on 
the critical need for lead-safe schools, daycare centers and Head Start facilities 
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due to the large proportion of lead-poisoned children who are repeatedly 
exposed while attending school. 
• 	 ACClPP should provide guidance to CDC on lead-poisoned children 0-5 years of 
age who are eligible for early intervention services, but do not receive these 
benefits from state health departments. 
• 	 ACClPP should establish a new workgroup to address the impact of educational 
interventions on lead-poisoned children. The workgroup's charge should focus 
on three key activities: (1) compile existing evidence; (2) review IDEA Parts C 
and 0, Special Education and model regulations to provide guidance to state and 
local governments; and (3) describe specific action steps for parents, clinicians 
and educators. 
• 	 CDC should encourage ClPPPs to continue to implement and enhance 
successful strategies for children with EBlls while new research is being 
generated. These approaches include nutritional interventions, developmental 
assessments at an early age, and strong linkages among childhood lead 
pOisoning, educational, case management and early intervention agencies. 
In response to the suggestion to make schools lead-safe, Dr. Brown emphasized that she would 
be extremely reluctant to devote lPPB funding and resources to this effort. She pointed out that 
a number of studies have found no clear relationship between EBlls and lead hazards in 
schools. She also noted that solid research has been produced to demonstrate an association 
between EBlls and lead paint in the homes of children. 
A motion was properly placed on the floor and seconded by Ms. Johnson and Dr. Sandel, 
respectively, for ACClPP to establish a new workgroup to address issues related to the 
educational implications of lead-poisoned children, development assessments and early 
intervention services for children 0-3 years of age. ACClPP unanimously approved the 
motion. 
The ACClPP members made several suggestions to guide the establishment of the new 
"Educational Interventions for lead-Exposed Children Workgroup." The workgroup should be 
represented by a diverse group of stakeholders in multiple sectors, including the medical and 
research communities, parents and grassroots organizations, to interpret IDEA and other laws 
with a unified voice. The representation of advocates on the workgroup will be critical to 
advance the recommendations beyond CDC's limitations as a federal agency. 
Dr. Walter Rogan, ACClPP's ex-officio member for the National Institute of Environmental 
Health Sciences, should serve on the workgroup to formulate concrete research strategies for 
intervention programs. A representative of the U.S. Department of Education also should be 
invited to serve on the workgroup to provide technical assistance. The workgroup's activities 
should not be limited to lead poisoning due to lPPB's ongoing efforts to transition to healthy 
housing. 
Dr. Brown confirmed that over the next six to eight weeks, actions would be taken to establish 
the workgroup with ACClPP members and liaisons, CDC staff, educational partners and other 
expertise as suggested by ACClPP. The workgroup would initially meet by conference call, but 
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face-to-face meetings would be convened in the future. Dr. Brown encouraged ACCLPP to 
provide her with additional input on the workgroup's composition and charge. 
The following ACCLPP members, liaisons and ex-officios volunteered to serve on the new 
workgroup: Ms. Johnson, Ms. Jordan, Ms. Kite, Ms. Mosby and Drs. Angeloni, Friedman, 
Keyvan-Larijani, Sandal and Gardner (based on her schedule). Dr. Brown and Ms. Connie 
Thomas, of LPPB, would represent CDC on the workgroup. 
Ms. Wendy Blumenthal, of LPPB, reported that the Interagency Workgroup on Import Safety 
was established by a Presidential Executive Order in July 2007. The workgroup is charged with 
performing a comprehensive review of current import safety practices and identifying areas 
where improvements can be made. The workgroup is represented by senior Administration 
officials, including HHS as the chair, EPA, Consumer Product Safety Commission (CPSC), 
Department of Homeland Security, Department of Justice, Department of State, Department of 
Commerce and U.S. Trade officials. 
The workgroup released a strategic framework in September 2007 and opened a public 
comment period for this document through October 2007. The workgroup subsequently 
released the "Action Plan for Import Safety" in November 2007 with 14 broad recommendations 
and 50 action steps in the areas of prevention, intervention and response. Each action step 
identifies a lead agency and outlines either a short- or long-term time frame. 
Ms. Blumenthal summarized the key recommendations and action items of the action plan. 
New and existing safety standards should be created and strengthened. This goal should be 
achieved by extending mandatory manufacturer or importer certification requirements to all 
CPSC statutes. Public-private sector programs should be used to develop safety standards that 
eventually could be adopted by federal agencies. 
Compliance of foreign producers should be verified through certification with U.S. safety and 
security standards. This goal should be achieved by requiring mandatory certification for high­
risk products governed by the Food and Drug Administration. Voluntary certification programs 
should be jointly developed by federal agencies, the importing community and other members of 
the public. 
Good importer practices should be promoted. Penalties should be enhanced and strong 
enforcement actions should be taken to ensure accountability. These goals should be achieved 
by amending the Consumer Product Safety Act (CPSA), Food, Drug and Cosmetic Act, and 
other laws to include asset-forfeiture remedies for criminal offenses. CPSA should be modified 
to raise the statutory civil penalty cap for a related series of violations to $10 million. 
Customs and Border Patrol mitigation guidelines should be strengthened. The maximum 
penalty for importers with repeat violations should be increased. The current requirement to 
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notify offending parties that violate CPSA should be removed. Product safety should be made 
an important principle of diplomatic relationships with foreign countries. The profile of relevant 
foreign assistance activities should be increased. 
Federal government procedures and requirements for processing import shipments should be 
harmonized across different federal agencies. A single window interface should be completed 
to facilitate the exchange of import data between federal agencies and the private sector. An 
Interactive Import Safety Information Network should be created. 
Laboratory capacity should be expanded and rapid test methods for quick identification of 
hazards should be developed. These goals should be achieved by strengthening field 
laboratory capacity for testing and developing analytical tools for enhanced rapid screening. 
Rapid test methods should be created to determine the admission of products to the United 
States. The protection of intellectual property rights should be enhanced to strengthen 
consumer safety. 
The effectiveness of product recalls should be maximized. This goal should be achieved by 
amending CPSA to make the sale of a product after recall illegal for any manufacturer, 
distributor or retailer. CPSC should be given authorization to follow-up recalls and require all 
recalling firms to provide the names and addresses of companies that supplied or received 
recalled products. 
Federal and state collaborations should be maximized. This goal should be achieved by 
reviewing admissibility policies to improve the use of evidence and laboratory results from state 
investigations. Consumer notification of product recalls should be expedited. This goal should 
be achieved by developing best practices in using Smart Cards and other product tracking 
technologies to expedite notification of recalls to consumers. The use of electronic track-and­
trace technologies should be expanded across the entire import life cycle. 
Ms. Blumenthal announced that both the House and Senate passed consumer product 
legislation in December 2007 and March 2008, respectively. The bill was resubmitted to the 
House for another vote after the Senate made amendments and will be enacted at the time of 
the President's signature. The bill calls for CPSC reauthorization with an annual increase in 
appropriations, an increase of -$26 million in 2009, an increase of $155 million by 2015, an 
increase in staff to at least 500 personnel, and 50 new personnel at ports of entry. 
The consumer product legislation further calls for a ban on children's products with lead and 
would be enforced one year from enactment. The ban would cover any product or its part, 
including jewelry, that contains lead or lead compounds >0.03% in weight based on the total 
weight of the part. The ban would reduce the threshold from >0.03% to 0.01 % from three years 
of enactment, but CPSC would be required to propose an alternative measurement if the 
reduced threshold is found to be technologically unfeasible. 
Exceptions to the ban would include components that are inaccessible within the product, 
certain electronics and possibly lead crystal. The ban also calls for a change in the paint 
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standard from 0.06% to 0.009% for all products that fall under CPSA. Similar to the ban on 
children's products, the ban on paint also would be enforced one year from enactment. 
The consumer product legislation proposes to increase caps for civil penalties under both CPSA 
and the Federal Hazardous Substances Act. The maximum civil penalty for a single violation 
would increase from $5,000 to $250,000. The maximum civil penalty for a series of violations 
would increase from $1.25 million to $20 million. CPSC would initiate rulemaking for additional 
criteria for civil penalties. The maximum length of time of imprisonment for knowing and willful 
violations would increase from one year to five years. 
CPSC would partner with the National Academy of Sciences and the National Institute of 
Standards and Technology to study the feasibility of establishing a standardized measure for 
lead content based on a unit of mass per area rather than the current measure of lead 
concentrations. Procedures would be developed to certify and monitor activities by independent 
laboratories that test for adherence to federal safety standards. 
Ms. Blumenthal described a new project that LPPB and ATSDR are jointly conducting to 
improve risk assessment and identification of lead sources. This effort was initiated in response 
to a request for guidance by a local health department in Missouri. The health department 
informed A TSDR of its inability to remove lead-contaminated products from facilities that are 
found during food and other routine inspections. 
LPPB and ATSDR will conduct a number of activities to support the new project: (1) develop 
and distribute sampling and testing guidance, tools and other resources to risk assessors; (2) 
identify and disseminate various strategies to enforce lead violations; (3) enhance knowledge of 
existing reporting mechanisms to state and federal agencies; and (4) establish an interstate 
alert system to improve surveillance and data exchange of lead-contaminated products across 
different states. The project will result in the development of a guidance document and the 
provision of training to assist programs in using this tool. 
LPPB and ATSDR will take several actions to advance the project: (1) convene internal 
conference calls to determine staff resources, (2) draft an outline of the guidance document, (3) 
conduct site visits to ATSDR Region 7 to better understand issues at the local level, (4) contact 
programs to obtain information on successful models and lessons learned, and (5) solicit 
additional input from federal partners. 
Dr. Michael Kosnett is an ACCLPP member and chair of the workgroup that was established to 
formulate recommendations on the import, export and disposal of lead-containing toys and other 
products to children. He reported that after the September 2007 meeting, the workgroup drafted 
a letter to Dr. Julie Gerberding, Director of CDC, and forwarded the document to the ACCLPP 
voting members for review and comment. 
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The letter was revised, finalized, formally approved by the voting members, and sent to Dr. 
Gerberding on November 24, 2007. Dr. Gerberding forwarded ACCLPP's letter to the HHS 
Secretary on March 3, 2008. ACCLPP's letter, attachments and Dr. Gerberding's response 
were included in the meeting packets for review. 
Dr. Kosnett announced that the workgroup would convene a conference call over the next two 
weeks to discuss next steps to advance ACCLPP's import safety recommendations beyond the 
letter to Dr. Gerberding. In the interim, he requested ACCLPP's input on this issue and raised a 
number of key points to guide the discussion. 
• 	 Additional information is needed about risk assessments that were performed 
and the extent to which CDC or CPSC provided expertise in proposing the new 
thresholds for lead in products and paint in the consumer product legislation. 
This information is needed to determine whether the new thresholds would be 
protective of health. 
• 	 The proposed bill does not mention ACCLPP's recommendation to promote a 
worldwide ban on the use of lead in products commonly used by children. 
ACCLPP should follow-up with the HHS Secretary to make a stronger case for 
this particular issue. 
• 	 Support and resources are needed to advance ACCLPP's recommendation to 
convene an international public health conference and other educational 
activities to increase lead hazard awareness among key u.S. trading partners. 
For example, HHS or the Department of State could establish public-private 
partnerships to leverage resources for this effort. 
• 	 Additional information is needed on whether recalls outlined in the Action Plan for 
Import Safety would apply to the export of products. 
• 	 Clarification is needed on whether ACCLPP, as a federal advisory committee, 
would be allowed to provide educational testimony to Congress on import safety. 
Ms. Lori Saltzman, ACCLPP's ex-officio member for CPSC, joined the meeting by conference 
call. She announced that CPSC would convene a meeting in May 2008 to review provisions in 
the proposed consumer product legislation, including those addressing lead. The meeting 
would be open to the public with time set aside for public comment. She would provide Dr. 
Brown with additional details about the meeting for circulation to ACCLPP. 
Ms. Saltzman reported that she was unable to respond to Dr. Kosnett's requests for additional 
information on recalls of exported products and the risk assessment process used to propose 
the new thresholds for lead in products and paint in the consumer product legislation. She 
confirmed that she would provide Ms. Blumenthal with contact information for the head of the 
Office of Compliance to assist the workgroup in obtaining more details about these issues. 
In terms of ACCLPP's recommendation to convene an international public health conference, 
Ms. Saltzman noted that CPSC's International Program frequently communicates with China 
and other countries. CPSC also has established technical workgroups to educate importers and 
manufacturers in various countries about U.S. regulations. She conveyed that CPSC's existing 
--------.--------­
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relationships with other countries might serve as a valuable resource in convening an 
international public health conference. 
Dr. Brown made several remarks in response to the comments by Dr. Kosnett and Ms. 
Saltzman. The HHS Secretary has 30 days from March 3, 2008 to respond to ACCLPP's letter. 
After April 3, 2008, the letter would be placed in the public domain for individual ACCLPP 
members or other groups to use or widely disseminate. 
In terms of the upcoming CPSC meeting, Dr. Brown would follow-up with the CDC Committee 
Management Office to determine whether ACCLPP should provide public comments as a formal 
advisory committee or if individual members should give public comments as private citizens. 
To assist in advancing ACCLPP's import safety recommendations, Dr. Brown would convene a 
conference call with the ACCLPP workgroup and federal staffers on the Interagency Workgroup 
on Import Safety. She emphasized that strategies in this effort would be limited because 
ACCLPP voting members are special government employees and are prohibited from lobbying. 
However, individual ACCLPP members are free to contact their elected officials or sponsors of 
the consumer product legislation as private citizens. 
Dr. Brown noted that she would give serious consideration to this matter to assure ACCLPP's 
transparency to the public in "educating" rather than "lobbying" Congress. She would contact 
the Committee Management Office to determine whether ACCLPP, as a federal advisory 
committee, would be allowed to provide educational testimony to Congress or give briefings to 
staffers on import safety. She would report her findings to ACCLPP the week of March 24, 
2008. 
The ACCLPP members made a number of suggestions to advance the import safety guidance. 
• Partnerships should be established with the World Health Organization's Office 
of Children's Environmental Health, the Chinese government and other 
international agencies to leverage public funding to convene an international 
public health conference. 
• Academic institutions, foundations and other groups should be contacted to 
leverage private funding to convene an international public health conference. 
• ACCLPP's liaison members for AFHH, the American Academy of Pediatrics and 
the American Public Health Association (APHA) should ask their respective 
organizations to take the following actions: (1) lobby and advocate for the 
consumer product legislation after ACCLPP's import safety recommendations 
become a part of the public domain; (2) broadly distribute ACCLPP's guidance; 
and (3) give Congressional testimony on import safety. 
• Additional information should not be requested at this time on the risk 
assessment process that was used to propose the new thresholds for lead in 
products and paint in the consumer product legislation. The Congressional 
authorization process for this bill is underway. After the bill is authorized and 
appropriated, ACCLPP should determine whether the new thresholds are 
protective of health and provide guidance at that time if needed. 
------ ...--------------
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Dr. Brown announced that the terms of three ACCLPP members would expire after the current 
meeting. Ms. Valarie Johnson was acknowledged as the first ACCLPP member to represent 
parents. She is the mother of a child with an EBLL and a tireless advocate for childhood lead 
poisoning. 
Dr. Kevin Stephens was recognized for his service on both ACCLPP and LPWG. He was also 
commended for his valuable expertise and support to CDC in rebuilding the Louisiana CLPPP 
following Hurricane Katrina. Dr. Stephens is the Health Director of the New Orleans 
Department of Health. Dr. Wayne Snodgrass was recognized for contributing his tremendous 
expertise on lead toxicity to ACCLPP and CDC. 
Dr. Brown presented plaques to the three outgoing members to formally acknowledge their 
outstanding dedication, commitment and contributions to ACCLPP, CDC and the health of 
children in the United States. 
Dr. Brown provided clarification in response to Dr. Angeloni's questions regarding new members 
and future meeting agendas. Current and former ACCLPP members, federal agency staff, non­
governmental organizations and the general public can nominate potential candidates. The 
initial slate of nominees is submitted to Dr. Gerberding and the HHS Secretary. 
The CDC Director has delegated responsibility to Dr. Brown to determine whether ACCLPP 
nominees have relevant scientific expertise and other appropriate qualifications to meet the 
charter requirements for a fairly balanced committee in terms of points of view represented. 
After the internal review, CDC submits the final slate of nominees to the HHS Secretary. The 
final selection and approval of new members are beyond CDC's control and are at the discretion 
of the HHS Secretary. 
For the current rotation, Dr. Brown announced that the HHS Secretary has confirmed three new 
members who will replace the three outgoing members. One of the new members is the parent 
of a lead-poisoned child. Dr. Brown encouraged ACCLPP to provide her with names of 
potential candidates on a regular basis because formal approval of a new member is a six- to 
nine-month process. Moreover, three candidates must be nominated for every one outgoing 
member. 
In terms of future agendas, Dr. Brown pointed out that LPPB polls the ACCLPP members by e­
mail following each meeting to obtain suggestions on potential topics. She explained that 
agendas of all federal adviSOry committees are required to be announced in the Federal 
Register 60 days in advance of a meeting. 
Mr. Barry Brooks, of LPPB, confirmed that the ACCLPP members would be polled bye-mail the 
first week of July 2008 to suggest potential agenda items for the October 2008 meeting. 
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Dr. Rhoads opened the floor for public comments; no participants responded. 
The next ACCLPP meeting would be held in San Diego, California on October 29-30,2008. To 
accommodate the schedules of persons who would attend APHA's annual conference, the 
ACCLPP meeting would be structured for the half-day session to be held on day 1 and the full­
day session to be held on day 2. 
ACCLPP applauded Mr. Brooks, Ms. Claudine Johnson and other LPPB staff for providing 
outstanding administrative support and making logistical arrangements for the meeting. 
With no further discussion or business brought before ACCLPP, Dr. Rhoads adjourned the 
meeting at 12:35 p.m. on March 19, 2008. 
I hereby certify that to the best of my 
knowledge, the foregoing Minutes of the 
proceedings are accurate and complete. 
Date 	 George G. Rhoads, M.D., M.P.H. 
Chair, AdviSOry Committee on 
Childhood Lead Poisoning Prevention 
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